KUMAR, Kunal,WANG, Peng,SANCHEZ, Roberto,OCANA, Adolfo, Garcia,STEWART, Andrew,DEVITA, Robert
申请号：
AU2019240065
公开号：
AU2019240065A1
申请日:
2019.03.20
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Described herein are compounds having the following structure: formula (I) or a stereoisomer, pharmaceutically acceptable salt, oxide, or solvate thereof. Also disclosed are compositions containing the compounds, methods of inhibiting activity of DYRKl A in a cell, methods of increasing cell proliferation in a population of pancreatic beta cells, methods of treating a subject for a condition associated with insufficient insulin secretion, and methods of treating a subject for a neurological disorder.
